Antibacterial Activity of Colloidal Silver against Gram-Negative and Gram-Positive Bacteria
Open Access
- 18 January 2020
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 9 (1), 36
- https://doi.org/10.3390/antibiotics9010036
Abstract
Due to the emergence of antimicrobial resistance, new alternative therapies are needed. Silver was used to treat bacterial infections since antiquity due to its known antimicrobial properties. Here, we aimed to evaluate the in vitro activity of colloidal silver (CS) against multidrug-resistant (MDR) Gram-negative and Gram-positive bacteria. A total of 270 strains (Acinetobacter baumannii (n = 45), Pseudomonas aeruginosa (n = 25), Escherichia coli (n = 79), Klebsiella pneumoniae (n = 58)], Staphylococcus aureus (n = 34), Staphylococcus epidermidis (n = 14), and Enterococcus species (n = 15)) were used. The minimal inhibitory concentration (MIC) of CS was determined for all strains by using microdilution assay, and time–kill curve assays of representative reference and MDR strains of these bacteria were performed. Membrane permeation and bacterial reactive oxygen species (ROS) production were determined in presence of CS. CS MIC90 was 4–8 mg/L for all strains. CS was bactericidal, during 24 h, at 1× and 2× MIC against Gram-negative bacteria, and at 2× MIC against Gram-positive bacteria, and it did not affect their membrane permeabilization. Furthermore, we found that CS significantly increased the ROS production in Gram-negative with respect to Gram-positive bacteria at 24 h of incubation. Altogether, these results suggest that CS could be an effective treatment for infections caused by MDR Gram-negative and Gram-positive bacteria.Funding Information
- Instituto de Salud Carlos III (PI16/01378, PI16/01306, CP15/00132, CM18/00122)
This publication has 32 references indexed in Scilit:
- Silver Enhances Antibiotic Activity Against Gram-Negative BacteriaScience Translational Medicine, 2013
- Prospective Multicenter Study of the Impact of Carbapenem Resistance on Mortality in Pseudomonas aeruginosa Bloodstream InfectionsAntimicrobial Agents and Chemotherapy, 2012
- Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteriaJournal of Applied Microbiology, 2012
- Rifampin Protects Human Lung Epithelial Cells Against Cytotoxicity Induced by Clinical Multi and Pandrug-resistant Acinetobacter baumanniiThe Journal of Infectious Diseases, 2011
- The SoxRS response of Escherichia coli is directly activated by redox‐cycling drugs rather than by superoxideMolecular Microbiology, 2011
- Comparison of the Antimicrobial Effects of Chlorine, Silver Ion, and Tobramycin on BiofilmAntimicrobial Agents and Chemotherapy, 2008
- Antimicrobial effects of silver nanoparticlesNanomedicine: Nanotechnology, Biology and Medicine, 2007
- Does the Antibacterial Activity of Silver Nanoparticles Depend on the Shape of the Nanoparticle? A Study of the Gram-Negative Bacterium Escherichia coliApplied and Environmental Microbiology, 2007
- Involvement of Reactive Oxygen Species in the Action of Ciprofloxacin againstEscherichia coliAntimicrobial Agents and Chemotherapy, 2006
- Silver in Health Care: Antimicrobial Effects and Safety in UseCurrent problems in dermatology, 2006